The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
hZIP1 zinc uptake transporter down regulation and zinc depletion in prostate cancer
Open accessAbstract
Background: The genetic and molecular mechanisms responsible for and associated with the development and progression of prostate malignancy are largely unidentified. The peripheral zone is the major region of the human prostate gland where malignancy develops. The normal peripheral zone glandular epithelium has the unique function of accumulating high levels of zinc. In contrast, the ability to accumulate zinc is lost in the malignant cells. The lost ability of the neoplastic epithelial cells to accumulate zinc is a consistent factor in their development of malignancy. Recent studies identified ZIP1 (SLC39A1) as an important zinc transporter involved in zinc accumulation in prostate cells. Therefore, we investigated the possibility that down-regulation of hZIP1 gene expression might be involved in the inability of malignant prostate cells to accumulate zinc. To address this issue, the expression of hZIP1 and the depletion of zinc in malignant versus non-malignant prostate glands of prostate cancer tissue sections were analyzed. hZIP1 expression was also determined in malignant prostate cell lines. Results: hZIP1 gene expression, ZIP1 transporter protein, and cellular zinc were prominent in normal peripheral zone glandular epithelium and in benign hyperplastic glands (also zinc accumulating glands). In contrast, hZIP1 gene expression and transporter protein were markedly down-regulated and zinc was depleted in adenocarcinomatous glands and in prostate intra-epithelial neoplastic foci (PIN). These changes occur early in malignancy and are sustained during its progression in the peripheral zone. h ZIP1 is also expressed in the malignant cell lines LNCaP, PC-3, DU-145; and in the nonmalignant cell lines HPr-1 and BPH-1. Conclusion: The studies clearly establish that hZIP1 gene expression is down regulated and zinc is depleted in adenocarcinomatous glands. The fact that all the malignant cell lines express hZIP1 indicates that the down-regulation in adenocarcinomatous glands is likely due to in situ gene silencing. These observations, coupled with the numerous and consistent reports of loss of zinc accumulation in malignant cells in prostate cancer, lead to the plausible proposal that down regulation of hZIP1 is a critical early event in the development prostate cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kurhanewicz, J. V., Swanson, M. G., Nelson, S. J., & Vigneron, D. B. (2002) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.10172 · Cited by 351
Functional Expression of the Human hZIP2 Zinc Transporter
Gaither, L. A., & Eide, D. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.8.5560 · Cited by 327
Costello, L. C., & Franklin, R. B. (1998) · The Prostate · doi:10.1002/(sici)1097-0045(19980601)35:4<285::aid-pros8>3.0.co;2-f · Cited by 297
Self-citationLi, H., Myeroff, L., Smiraglia, D., Romero, M. F., Pretlow, T. P., Kasturi, L., Lutterbaugh, J., Rerko, R. M., Casey, G., Issa, J.-P., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1430846100 · Cited by 295
Miyauchi, S., Gopal, E., Fei, Y.-J., & Ganapathy, V. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400059200 · Cited by 282
Costello, L. C., Liu, Y., Franklin, R. B., & Kennedy, M. C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.46.28875 · Cited by 267
Self-citationZinc in the human prostate gland: Normal, hyperplastic and cancerous
Zaichick, V. Y., Sviridova, T. V., & Zaichick, S. V. (1997) · International Urology and Nephrology · doi:10.1007/bf02552202 · Cited by 265
Costello, L. C., & Franklin, R. B. (2000) · Oncology · doi:10.1159/000012183 · Cited by 248
Self-citationCostello, L. C., Liu, Y., Zou, J., & Franklin, R. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.25.17499 · Cited by 224
Self-citationGenetics of Prostate Cancer: Too Many Loci, Too Few Genes
Ostrander, E. A., & Stanford, J. L. (2000) · The American Journal of Human Genetics · doi:10.1086/316916 · Cited by 198
Costello, L. C., Franklin, R. B., & Feng, P. (2005) · Mitochondrion · doi:10.1016/j.mito.2005.02.001 · Cited by 193
Self-citationRole of zinc in the pathogenesis and treatment of prostate cancer: critical issues to resolve
Costello, L. C., Feng, P., Milon, B., Tan, M., & Franklin, R. B. (2004) · Prostate Cancer and Prostatic Diseases · doi:10.1038/sj.pcan.4500712 · Cited by 178
Self-citationHuman ZIP1 is a major zinc uptake transporter for the accumulation of zinc in prostate cells
Franklin, R. B., Ma, J., Zou, J., Guan, Z., Kukoyi, B. I., Feng, P., & Costello, L. C. (2003) · Journal of Inorganic Biochemistry · doi:10.1016/s0162-0134(03)00249-6 · Cited by 171
Self-citationZinc and magnesium in human prostate gland: normal, hyperplastic, and neoplastic.
Györkey, F., Min, K., Huff, J. A., & Györkey, P. (1967) · PubMed · Cited by 167
The human tumour suppressor gene SLC5A8 expresses a Na+–monocarboxylate cotransporter
Coady, M. J., Chang, M., Charron, F. M., Plata, C., Wallendorff, B., Sah, J. F., Markowitz, S. D., Romero, M. F., & Lapointe, J. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2004.063859 · Cited by 166
Direct effect of zinc on mitochondrial apoptogenesis in prostate cells
Feng, P., Li, T., Guan, Z., FRANKLIN, R. B., & Costello, L. C. (2002) · The Prostate · doi:10.1002/pros.10128 · Cited by 153
Self-citation‘Why do tumour cells glycolyse?’: From glycolysis through citrate to lipogenesis
Costello, L. C., & FRANKLIN, R. B. (2005) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-005-8841-8 · Cited by 150
Self-citationZinc and zinc transporters in normal prostate function and the pathogenesis of prostate cancer
Renty, B. F. (2005) · Frontiers in bioscience · doi:10.2741/1692 · Cited by 113
Porra, V., Ferraro‐Peyret, C., Durand, C., Selmi‐Ruby, S., Giroud, H., Berger-Dutrieux, N., Decaussin‐Petrucci, M., Peix, J., Bournaud, C., Orgiazzi, J., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1394 · Cited by 108
Zinc induces mitochondria apoptogenesis in prostate cells.
Feng, P., Liang, J. Y., Li, T. L., Guan, Z., Zou, J., FRANKLIN, R. B., & Costello, L. C. (2000) · PubMed · Cited by 103
Self-citationBiological functions of SLC5A8, a candidate tumour suppressor
Ganapathy, V., Gopal, E., Miyauchi, S., & Prasad, P. D. (2005) · Biochemical Society Transactions · doi:10.1042/bst0330237 · Cited by 101
Molecular Mechanisms of Prostate Cancer
Porkka, K. P., & Visakorpi, T. (2004) · European Urology · doi:10.1016/j.eururo.2004.01.012 · Cited by 93
Prostate Cancer in African American Men Is Associated With Downregulation of Zinc Transporters
Rishi, I., Baidouri, H., Abbasi, J. A., Bullard-Dillard, R., Kajdacsy‐Balla, A., Pestaner, J. P., Skacel, M., Tubbs, R., & Bagasra, O. (2003) · Applied immunohistochemistry & molecular morphology · doi:10.1097/00129039-200309000-00009 · Cited by 77
Self-citationAberrant Methylation and Histone Deacetylation Associated with Silencing of SLC5A8 in Gastric Cancer
Ueno, M., Toyota, M., Akino, K., Suzuki, H., Kusano, M., Satoh, A., Mita, H., Sasaki, Y., Nojima, M., Yanagihara, K., et al. (2004) · Tumor Biology · doi:10.1159/000079145 · Cited by 63
Dhar, N. K., Goel, T. C., Dube, P. C., Chowdhury, A., & Kar, A. B. (1973) · Experimental and Molecular Pathology · doi:10.1016/0014-4800(73)90073-7 · Cited by 55
Vartsky, D., Shilstein, S., Bercovich, A., Huszar, M., Breskin, A., Chechik, R., Korotinsky, S., Malnick, S. D. H., & Moriel, E. Z. (2003) · The Journal of Urology · doi:10.1097/01.ju.0000095795.86327.b8 · Cited by 47
Terminal oxidation and the effects of zinc in prostate versus liver mitochondria
Costello, L. C., GUAN, Z., Kukoyi, B. I., FENG, P., & FRANKLIN, R. (2004) · Mitochondrion · doi:10.1016/j.mito.2004.07.031 · Cited by 41
Self-citationDifferential expression of hZnT‐4 in Human prostate tissues
Beck, F. W. J., Prasad, A. S., Butler, C. E., Sakr, W., Küçük, Ö., & Sarkar, F. H. (2003) · The Prostate · doi:10.1002/pros.10344 · Cited by 39
Cited by
The Essential Toxin: Impact of Zinc on Human Health
Plum, L. M., Rink, L., & Haase, H. (2010) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph7041342 · Cited by 1,577
Mammalian Zinc Transport, Trafficking, and Signals
Cousins, R. J., Liuzzi, J. P., & Lichten, L. A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.r600011200 · Cited by 705
Chen, B., Yu, P., Chan, W. N., Xie, F., Zhang, Y., Liang, L., Leung, K. T., Lo, K. W., Yu, J., Tse, G. M. K., et al. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01679-y · Cited by 420
The emerging role of zinc transporters in cellular homeostasis and cancer
Bafaro, E., Liu, Y., Xu, Y., & Dempski, R. E. (2017) · Signal Transduction and Targeted Therapy · doi:10.1038/sigtrans.2017.29 · Cited by 307
Zinc in Specialized Secretory Tissues: Roles in the Pancreas, Prostate, and Mammary Gland
Kelleher, S. L., McCormick, N. H., Velasquez, V., & Lopez, V. (2011) · Advances in Nutrition · doi:10.3945/an.110.000232 · Cited by 263
Metadata
- Authors
- Franklin, R. B., Feng, P., Milon, B., Desouki, M. M., Singh, K. K., Kajdacsy-Balla, A., Bagasra, O., & Costello, L. C.
- Venue
- Molecular Cancer
- Published
- 2005-09-09
- Volume
- 4
- Issue
- 1
- Pages
- 32-32
- ISSN
- 1476-4598 (ISSN-L)
- OpenAlex
- W2129559645
- Cited by
- 270
- References
- 28
- FWCI
- 8.45
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.